H35.159
Retinopathy of prematurity, stage 4, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Retinopathy of prematurity (ROP) is a condition affecting the eyes of premature infants, involving abnormal development of blood vessels in the retina. When ROP reaches stage 4, it indicates significant progression characterized by a partial detachment of the retina. The classification 'unspecified eye' means that the condition affects one or both eyes, but the specific eye(s) involved is not detailed. Recognizing and understanding ROP stage 4 is crucial for timely management and preventing potential vision loss.
Causes & Symptoms
Clinical Causes: Premature birth, especially before 31 weeks of gestation Low birth weight (less than 1,500 grams or about 3 pounds, 5 ounces) Oxygen therapy administered to preterm infants, which can influence retinal blood vessel development Genetic factors that may predispose infant to abnormal blood vessel growth Other factors affecting overall development and health of preterm infants
Key Symptoms: Partial visual impairment or difficulty focusing Abnormal eye movements Leukocoria, or a white reflection in the pupil in some cases Signs of retinal detachment in advanced stages, such as curtain-like visual loss No noticeable symptoms in early stages, often detected during routine eye examinations
Diagnostic & Treatment
Diagnosis Path: Diagnosis of stage 4 ROP involves detailed eye examinations by a specialist, typically using ophthalmoscopy to visualize the retina. Additional imaging techniques, such as retinal scans or fluorescein angiography, may be used to assess the extent of abnormal blood vessels and retinal detachment. The staging of ROP is based on the location and severity of abnormal vessel growth and detachment, with stage 4 indicating partial detachment.
Treatment Protocols: Laser therapy or cryotherapy to stop abnormal blood vessel growth and prevent progression Surgical procedures, such as vitrectomy, to remove scar tissue and repair retinal detachment Close monitoring and follow-up to assess disease progression and response to treatment Supportive measures tailored to the infant’s overall health and vision needs
Clinical Advice & FAQs
Billing Guidance
Is H35.159 a billable ICD-10 code?
Yes, H35.159 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.159?
Clinical documentation must specify the nature of Retinopathy of prematurity, stage 4, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference